News Conference News ACC 2026 Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering Michael O'Riordan April 01, 2026
News Conference News ACC 2026 PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV Michael O'Riordan March 29, 2026
News Conference News ACC 2026 Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE Yael L. Maxwell March 28, 2026
News Daily News Epicardial Fat Shows Promise as a Clinical Risk Factor for CAD Yael L. Maxwell March 24, 2026
News Daily News Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines Michael O'Riordan March 13, 2026
News Daily News AHA Forecast: CV Risk Factors in Women, Girls Headed in Wrong Direction L.A. McKeown March 03, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2026 Michael O'Riordan March 02, 2026
News Conference News EAPCI 2026 SCAD-Related MI Not Just the Domain of Young Women: Serbian Registry Caitlin E. Cox February 27, 2026
News Daily News Side Effects of Statins Might Be Overstated: CTT Collaboration Michael O'Riordan February 12, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2026 Caitlin E. Cox February 02, 2026
News Daily News Chemo-Induced Vascular Dysfunction More Likely When Breast Cancer Occurs After Menopause Yael L. Maxwell January 23, 2026
News Daily News Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment Yael L. Maxwell January 21, 2026
News Daily News Public Reporting Tied to Better Care, but Similar Outcomes, in Stroke Centers Todd Neale January 16, 2026
News Daily News JACC Debuts Data Digest on CV Health in the United States Caitlin E. Cox January 12, 2026
News Daily News Statins Work for Primary Prevention Even in Low-risk Patients With Type 2 Diabetes Todd Neale January 05, 2026
News Daily News Better LDL Control After STEMI Means Less Neoatherosclerosis Yael L. Maxwell December 23, 2025